oxonic acid has been researched along with Chemotherapy-Induced Febrile Neutropenia in 1 studies
Oxonic Acid: Antagonist of urate oxidase.
Chemotherapy-Induced Febrile Neutropenia: FEVER accompanied by a significant reduction in NEUTROPHIL count associated with CHEMOTHERAPY.
Excerpt | Relevance | Reference |
---|---|---|
"Patients with stage III gastric cancer who underwent D2 gastrectomy were enrolled." | 3.01 | Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer. ( Hirahara, N; Hyakudomi, R; Ishitobi, K; Kaji, S; Matsubara, T; Tajima, Y; Takai, K; Uchida, Y; Yamamoto, T, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Hirahara, N | 1 |
Matsubara, T | 1 |
Kaji, S | 1 |
Yamamoto, T | 1 |
Hyakudomi, R | 1 |
Takai, K | 1 |
Ishitobi, K | 1 |
Uchida, Y | 1 |
Tajima, Y | 1 |
1 trial available for oxonic acid and Chemotherapy-Induced Febrile Neutropenia
Article | Year |
---|---|
Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer.
Topics: Adenocarcinoma; Aged; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy | 2021 |